The effects of treatment with nitroglycerin (ING) and methoxamine on the degree of ischemic injury occurring during 5 hours of coronary occlusion were studied in 31 closed-chest sedated dogs. Acute coronary occlusion was produced by inflating a cuff previously implanted around the left anterior descending coronary artery. After 10 min of ischemia (assessed by intramyocardial electrodes), dogs were randomized into control and treated groups. Treated dogs received i.v. TNG during the remainder of the 5 hour occlusion. Arterial pressure was maintained at preinfusion levels with i.v. methoxamine. Six of 16 control dogs died; three of 15 treated dogs died. After 24 hours severity of infarct was assessed in survivors by gross inspection, and more quantitatively, by measurement of creatine phosphokinase (CPK) content of myocardium adjacent to each electrode. Transmural infarction was observed in all of the ten surviving control animals but in only two of the 12 treated animals. In control dogs, CPK was inversely related to ST segment elevation observed after 10 min of occlusion: the greater the ST elevation, the lower the inyocardial CPK level. This relation was modified in the treated group: at comparable initial levels of ischemia (as judged by ST segment elevation prior to treatment), treated dogs had significantly less CPK depression than control dogs (P < 0.025). Moreover, in controls, a significant reduction in CPK occurred at 48 of 57 electrode sites where ST elevation was observed after 10 min of occlusion. Only 19 of 69 such sites showed significant CPK reduction in the treated dogs (P < 0.001). Thus, administration of TNG, with support of arterial pressure by methoxamine, markedly reduces the severity and extent of infarction occurring after 5 hours of coronary occlusion in the dog.
SUMMARY
The effects of treatment with nitroglycerin (ING) and methoxamine on the degree of ischemic injury occurring during 5 hours of coronary occlusion were studied in 31 closed-chest sedated dogs. Acute coronary occlusion was produced by inflating a cuff previously implanted around the left anterior descending coronary artery. After 10 min of ischemia (assessed by intramyocardial electrodes), dogs were randomized into control and treated groups. Treated dogs received i.v. TNG during the remainder of the 5 hour occlusion. Arterial pressure was maintained at preinfusion levels with i.v. methoxamine. Six of 16 control dogs died; three of 15 treated dogs died. After 24 hours severity of infarct was assessed in survivors by gross inspection, and more quantitatively, by measurement of creatine phosphokinase (CPK) content of myocardium adjacent to each electrode. Transmural infarction was observed in all of the ten surviving control animals but in only two of the 12 treated animals. In control dogs, CPK was inversely related to ST segment elevation observed after 10 min of occlusion: the greater the ST elevation, the lower the inyocardial CPK level. This relation was modified in the treated group: at comparable initial levels of ischemia (as judged by ST segment elevation prior to treatment), treated dogs had significantly less CPK depression than control dogs (P < 0.025). Moreover, in controls, a significant reduction in CPK occurred at 48 of 57 electrode sites where ST elevation was observed after 10 min of occlusion. Only 19 of 69 such sites showed significant CPK reduction in the treated dogs (P < 0.001). Thus, administration of TNG, with support of arterial pressure by methoxamine, markedly reduces the severity and extent of infarction occurring after 5 hours of coronary occlusion in the dog. Additional Indexing Words: Myocardial ischemia IT IS TRADITIONALLY ACCEPTED that nitroglycerin is contraindicated for patients experiencing acute myocardial infarction. This concept rests upon the belief that nitroglycerin-induced hypotension and tachycardia aggravate ischemic injury. Experimental data demonstrate that either an increase in heart rate1' 2 or a decrease in arterial pressure1 3-5 increase ischemic injury (quantified by the magnitude of ST segment elevation recorded from acutely ischemic myocardium). However, one cannot assume that the net influence of nitroglycerin derives solely from its influence on heart rate or arterial pressure, since the drug has multiple actions not only on the systemic arterial vessels, veins, and coronary vasculature, but also on the distribution of myocardial blood flow. Thus, when nitroglycerin was administered to closed-chest dogs with acute coronary occlusion, it caused changes in arterial pressure and heart rate identical to those produced by hemorrhage, yet ST segment elevation diminished, rather than increased.3 When the hypotensive effect of nitroglycerin was prevented by methoxamine, an alpha-adrenergic agonist, an even greater reduction of ST segment elevation was observed.
These results suggested to us that nitroglycerin might reduce the degree of ischemic damage resulting from experimental acute myocardial infarction. In these experiments, however, coronary 291 occlusion lasted only 15 minutes. Moreover, it was not certain whether the nitroglycerin-induced decrease in ST segment elevation reflected a physiologically important reduction in ischemic injury. Therefore, to clarify the potential role of nitroglycerin during acute myocardial infarction, we evaluated the effects of this drug, with its hypotensive effects prevented by administration of methoxamine, on the severity and extent of myocardial infarction produced by a five hour period of coronary occlusion in the closed-chest sedated dog.
Methods
Thirty-one adult mongrel dogs of both sexes, weighing 15-24 kg, were studied. In preparation for definitive studies, each animal received general anesthesia and the heart was exposed through a left thoracotomy. An inflatable balloon cuff was placed around the left anterior descending coronary artery just distal to the first major branch. Ten intramyocardial electrodes were implanted. The location of the electrodes is shown in figure 1. Two or three electrodes were placed in regions judged to be outside of the zone of potential ischemia. The remaining electrodes were placed within the potentially ischernic zone. The electrode wires were insulated throughout their length (except for a 2 mm bare area which was within the myocardium) and were anchored at the epicardial surface by a lead bead. The wires were attached to a miniature electrical conductor, which was buried subcutaneously along with the catheter leading to the balloon cuff. Definitive studies were performed seven to 14 days after the operative procedure, when animals had recovered fully. Sedation was achieved with morphine (1.0-1.5 mg/kg) and diazepam (1.5-2.0 mg/kg) and maintained with supplemental diazepam as necessary. Arterial pressure was measured directly from the femoral artery. Intramyocardial electrograms (ECG) were recorded using a multichannel direct-writing recorder. The height of ST segments was measured 100 msec after the onset of the QRS deflection. No intraventricular conduction abnormalities leading to QRS lengthening were present at the times of ST segment measurement during occlusion.
At outset, baseline recordings of blood pressure and heart rate were made and animals were randomly allocated into control and treated groups. Treatment animals received i.v. nitroglycerin (an initial bolus of 450 mcg followed by a constant infusion of 300 mcg/min); small bolus doses of methoxamine (0.16-0.48 mg i.v.) were administered to treatment animals as necessary to maintain mean arterial pressure at the pretreatment level and thus to prevent reflex tachycardia. Control animals received no drugs. Acute coronary occlusion was produced by inflation of the balloon cuff. After 10 min of occlusion, the presence of myocardial ischemia was documented by ECG recordings. Animals in either the treatment or the control group having less than 2 mV ST segment elevation in four ECG leads were excluded from the study.
(Preliminary experiments showed that animals with less than this amount of ECG change frequently had little or no subsequent gross or biochemical evidence of ischemic damage.) Two experimental protocols were used in the definitive studies. In each series of experiments the coronary artery was occluded for five hours, and treatment was maintained until release of occlusion by cuff deflation. In one series, however (consisting of 11 control and nine treated dogs), a single 5 hour period of coronary artery occlusion was employed. Treatment was begun immediately after 10 min postocclusion ECG recordings were obtained, and arterial pressure was maintained at postocclusion, pretreatment levels. In the second series (consisting of five control and six treated animals), the coronary artery was occluded twice. The first occlusion, for purposes of determining pretreatment ST segment changes, lasted 10 min. The balloon cuff was then deflated, occlusion-induced ECG changes disappeared and dogs were then randomized. Forty to 60 minutes after deflation and prior to reinflation, nitroglycerin and methoxamine infusions were started in the treated group. After a brief period necessary to achieve hemodynamic stability in the treated group (10 min), the 5 hour period of coronary occlusion was begun. Arterial pressure in these dogs was maintained at the level recorded immediately prior to nitroglycerin and methoxamine administration, and hence prior to the second coronary occlusion. There were no differences between the observations made with these two experimental protocols. The data from the two different series were thus grouped for the purposes of data analysis. No attempt was made to suppress arrhythmic activity occurring during or after occlusion.
Twenty-four hours after the beginning of the 5 hour occlusion, with no interim treatment administered to any dog, the animals were anesthetized with pentobarbital sodium. The hearts were removed rapidly and immediately placed in iced saline. Coronary arteries were examined for patency throughout their length. Two treated dogs were found to have occluded coronaries at or just distal to the cuff, and were eliminated from subsequent analysis. The endocardial and epicardial surfaces of the left ventricle were inspected for gross evidence of myocardial infarction. Full thickness cylindrical biopsies (4 mm diameter) were taken from the area immediately adjacent to each electrode site, avoiding the actual electrode track. This specimen was weighed and assayed immediately for creatine phosphokinase (CPK) content. The biopsies were homogenized in 2 ml of 0.01 M phosphate buffer (pH 7.2) containing 0.01 M sodium EDTA, 0.01 Tris HC1, and 0.01 M glutathione. The homogenizer was rinsed with 2 ml of the isolation medium which was combined with the homogenate. The homogenate was centrifuged at 90,000 X G for 30 min and the supernatant diluted to an appropriate concentration for assay. One ml of the final dilution of supernatant corresponded to approximately 0.1 mg of fresh tissue. CPK assay was performed at 30°C according to the optical density method of Rosalki,6 using a Beckman spectrophotometer #DU-2. CPK activity is expressed as international milliunits per milligram of wet weight tissue.
The mean CPK value for 77 specimens obtained from animals not subjected to coronary occlusion was 960 milliunits/mg tissue (wet weight) with a standard deviation of 140. Thus, the lower limit of normal (using 95% confidence limits) was 680 milliunits/mg tissue. In order to preclude the possibility that nitroglycerin or methoxamine could, in themselves, alter myocardial CPK in a nonspecific manner, two nonischemic dogs were given nitroglycerin and methoxamine for five hours according to the experimental protocol. The CPK values that were subsequently determined were indistinguishable from those of the nonischemic dogs not receiving the drugs. Results
Effects of Coronary Occlusion and of Treatment
on Heart Rate and Arterial Pressure Table 1 shows the heart rate and arterial pressure data of the control and treated groups during the course of coronary occlusion. Neither heart rate nor blood pressure differed significantly between the two groups at any time during the study. Both groups manifested a slight rise in heart rate 10 min after occlusion. Arterial pressure varied within relatively narrow limits during the 5 hour period of occlusion. No significant hypertension or hypotension was noted.
Effect of Treatment on ST Segment Elevation
For purposes of comparison the total number of millivolts of ST segment elevation was summed for Circulation, Volume XLIX, February 1974 each animal for each point in time. This value (EST) is used as an index of the severity of ischemia.' Figure 2 depicts the time course of the average Y.ST during the 5 hour occlusion. Ten minutes after occlusion was begun (and before the start of treatment), there was no significant difference in degree of ST segment elevation between the control and treated groups, nor was there any significant difference in the number of electrode sites with ST segment elevation. After 30 min of occlusion mean EST was unchanged in the control group. In the treated group, however, mean EST decreased from 56 + 7 at 10 min (before treatment) to 43 + 8 mV (SE) at 30 min. Attenuation of ischemic ECG changes persisted in the treated group throughout the period of occlusion. Thus, mean EST remained significantly lower in the treated group than in the control group after 30, 60, and 120 min of occlusion. After 120 min mean EST fell in both treated and control groups, presumably representing the usual pattern of ECG evolution seen in acute myocardial infaretion.
Effect of Treatment on Survival and on Gross Pathology
The over-all results of the experiment are depicted in figure 3 . Six of the 16 control animals died during the 24 hour study period. Four died during the course of the occlusion (after 12, 19, 55, and 117 minutes) and two died the following night. In the treated group three animals died; one had ventricular fibrillation after 17 min of occlusion (6 min after treatment was begun), and the remaining two died the following night. Although there was a tendency for improved survival in the treated Abbreviations: HR = heart rate; BP = mean arterial pressure in mm Hg; n = number of dogs; Time is ini minutes.
Data represents measurements in all dogs sturviviing 24 hours after occlusion and hence those having myocardial CPK analysis performed. Values at zero time refer to determinations made either after occlusion but before treatment, or in dogs in which treatment was beguni befoie occlusion, prior to treatment and occltusion. The efficacy of treatment was assessed in a quantitative manner by relating the degree of pretreatment ischemia (ST elevation) in a particular location to the magnitude of myocardial damage (CPK reduction) ultimately observed in that same location ( fig. 4 ). After 10 min of occlusion and before treatment, the two groups of animals had equivalent degrees of ischemia as assessed by Y.ST segment elevation. The two groups also were equally ischemic as assessed by the number of electrode sites per animal with ST segment elevations greater than 3 mV. The mean number of electrode sites falling into this category was 5.7 per animal in the control group and 5.8 in the treated group. In the ten surviving control animals, Figure 4 -Percent of electrode sites exposed to an ischemic insult (at least 3 millivolts of ST segment elevation 10 min after acute coronary occlusion prior to treatment in the treated group) that after 5 hours of coronary occlusion had CPK values at least two standard deviations below the mean value for normal tissues. Reduction in CPK reflects ischemic damage. The difference between the control and the treated groups is highly significant, indicating a protective effect of treatment.
Circulation, Volume :~~:(0.,~:~:7 1-therefore, a total of 57 electrode sites showed ST segment elevation of 3 mV or more 10 min after start of occlusion. At the time of sacrifice 24 hours later, 48 of these 57 sites (84%) had signfficant CPK depression (more than two standard deviations below the mean of normal myocardial CPK). In the 12 treated animals that survived, there were 69 electrode sites with ST segment elevations of 3 mV or more 10 min after start of occlusion (but before treatment). Of these sites, only 19 (28%) showed significant depression of CPK content (P<0.001). Thus, those portions of myocardium manifesting the most severe degrees of ischemic ECG change were far less likely to develop biochemical signs of damage after five hours of coronary occlusion when the animal was treated with nitroglycerin and methoxamine. Figure 5 shows mean CPK content 24 hours after study plotted as a function of the magnitude of ST segment elevation at the same site measured 10 minutes following occlusion (but before nitroglycerin and methoxamine were started in the treated group). Data are shown for all 116 sites in control animals and 98 sites in treated animals. As anticipated, CPK content in both control and treated groups was inversely related to the magnitude of ST segment elevation. It is particularly 0-2 2.5-5 55-8 
Figure 5
Mean CPK values at sites having 10 min ST segment elevations within the range noted on the abscissa. The bar subtitled "normal" represents the mean value of 77 biopsies obtained from hearts not subjected to coronary occlusion. Numbers at bottom of each bar indicate the number of biopsies analyzed. P values refer to significance of difference between control and treated groups within each range of ST segment elevation. Results are expressed as mean +1 SE.
Circulation, Volume XLIX, February 1974 noteworthy that CPK content for any given degree of pretreatment ischemic ECG change was consistently much greater in treated animals. Thus, infusion with nitroglycerin and methoxamine over the five hours of coronary occlusion exerted a clear protective effect on the ultimate amount of ischemic damage in all locations regardless of the intensity of ischemnia present prior to treatment. Nitroglycerin and methoxamine actually appeared more effective in regions of more intense ischemia. Only slight depressions of CPK occurred after five hours of occlusion in sites which had manifested up to 8 mV of ST segment elevation after 10 min of occlusion. Such marked ST segment elevations were associated with a loss of more than 50% of myocardial CPK in untreated dogs. It was not until ST segment elevation was greater than 8 mV that more severe depressions in CPK occurred in the treated group. However, the extent of CPK depression was relatively modest even in these zones, where severe ischemia had been present before institution of treatment.
Discussion
A previous study from this laboratory demonstrated that the administration of nitroglycerin plus methoxamine (the latter administered in quantities sufficient only to prevent nitroglycerin-induced hypotensive effects) reduces the degree of ST segment elevation occurring during 15 min of acute coronary occlusion in the closed-chest sedated dog. 3 The inference drawn from the results was that ischemic injury occurring during acute myocardial infarction might be reduced by such a therapeutic intervention. However, the period of coronary occlusion employed was brief, and the physiologic significance of the decrease in ST segment elevation caused by the drugs was not clear. The results of the present investigation confirm and extend our original findings. During 5 hours of coronary occlusion in the closed-chest sedated dog, simultaneous administration of nitroglycerin and methoxamine 1) reduced the extent of ST segment elevation recorded by intramyocardial electrodes throughout the first 2 hours of coronary occlusion (fig. 2 ), 2) decreased the incidence of two serious sequelae (death or gross traiusmural infarction, fig. 3 ), and 3) diminished both the extent and severity of biochemically determined ischemic damage (figs. 2, 4, 5) .
Maroko and coworkers demonstrated ani inverse relationi between ST segment elevationi after 15 miil of coroniary occlusioni anid the degree of mvocardial CPK reduction measured 24 hours after occluisioni, thereby validating the use of acute ST segment changes as an index of subsequent ischemic damage.1' 7However, their model of acute infarction was an open-chest anesthesized dog; heart rates were usually above 150, and ST segment elevation was recorded from an exploring epicardial electrode. Our methods differ in that we studied ST segment changes in a closed-chest sedated animal with heart rates within the usual physiologic range and with electrograms recorded from chronically implanted intramyocardial electrodes. Nevertheless, our data ( fig. 5 ) parallel those of Maroko and coworkers in demonstrating an inverse relation between myocardial CPK content (measured 24 hours after the start of the 5 hour period of coronary occlusion) and the degree of ST segment elevation recorded 10 min after the beginning of coronary occlusion. Thus, the ST segment response to 10 min of coronary occlusion in the model employed in this investigation appears to be a valid index of the magnitude of ischemic injury.
This index was used to match zones of myocardium exposed to equivalent degrees of ischemic stress prior to the start of treatment. When sites with equal ischemia (pretreatment) were compared, the extent of subsequent CPK reduction, and presumably, the extent of ischemic damage,7 was significantly reduced in the treated group (fig. 5 ). In all but the severest regions of ischemia (pretreatment), reduction in CPK content was nearly eliminated in the treated group. These findings imply a reduction in both the extent (number of sites with loss of CPK content) and severity (magnitude of CPK reduction at each site) of myocardial damage induced by five hours of coronary occlusion.
In addition to the capacity to reduce ischemic injury, recent studies in our laboratory have demonstrated in the dog that nitroglycerin enhances electrical stability of the acutely ischemic ventricle8' 9 and that nitroglycerin combined with methoxamine reduces the incidence of spontaneous ventricular fibrillation occurring during acute coronary occlusion.9 Moreover, several clinical studies have shown that nitroglycerin'0 and other vasodilators" may improve hemodynamics in some patients with acute myocardial infarction complicated by left ventricular failure. Thus, contrary to popular belief, nitroglycerin may be uniquely valuable in the treatment of the patient experiencing an acute myocardial infarction providing that appropriate measures are taken to avoid excessive reduction in arterial pressure.
There are several possible mechanisms that might account for the salutary changes produced by nitroglycerin on the degree of myocardial ischemia accompanying coronary occlusion. For example, myocardial oxygen consumption (MVO2) may be diminished, resulting in a more favorable balance between myocardial oxygen supply and demand. Treatment with methoxamine abolished the reduction in arterial pressure produced by nitroglycerin; therefore, that component of a decrease in MVO2 dependent upon reduced pressure was excluded. Nonetheless, the beneficial effects of nitroglycerin could, at least in part, still be attributed to a reduction in MVO2 if the venous dilatation caused by nitroglycerin was not fully negated by the doses of methoxamine used in this study. If this were the case, venous pooling would occur, with resulting decrease in ventricular volume. Such a change, by the LaPlace relationship, would diminish myocardial wall tension (and thereby, MV02) for any given level of systolic pressure developed. It is also possible that the favorable effects of nitroglycerin reflect an increase in coronary flow to ischemic regions by dilatation of coronary collateral chan-nels12' 13 or by reduction in the intramural resistance to coronary flow during diastole owing to reduction in left ventricular diastolic volume and wall tension. 14 In conclusion, we have demonstrated that simultaneous administration of nitroglycerin and methoxamine is capable of preventing or reducing ischemic injury caused by a 5 hour period of coronary occlusion in the closed-chest sedated dog. Whether such a therapeutic intervention would be effective in a patient who might have lesions of multiple coronary vessels is uncertain. However, the results of the present investigation, in conjunction with those of other studies showing that nitroglycerin is capable of exerting beneficial electrophysiologic, antiarrhythmic, and hemodynamic effects, indicate a potentially important role for nitroglycerin in the therapy of acute myocardial infarction.
